<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/antx" ></link>
<id>urn:uuid:6415307d-8003-9722-8194-d0130702f5bf</id>
<updated>2026-10-31T18:40:36-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ANTX: MARKS GILBERT LYNN (DIR) Acquired (JB) 2,283 Shares of AN2 THERAPEUTICS INC for $0.00 on 10/12</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6480529" ></link>
<id>urn:uuid:e29e70e9-e7d8-fd93-9ce5-4e31827e0a7a</id>
<updated>2026-10-13T17:13:17-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: MARTIN PATRICIA A (DIR) Acquired (JB) 389 Shares of AN2 THERAPEUTICS INC for $0.00 on 10/12</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6480530" ></link>
<id>urn:uuid:4dbdc8d6-e38d-f8f9-88be-a3b632b1a474</id>
<updated>2026-10-13T17:12:52-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: AZIZ KABEER (DIR) Acquired (JB) 2,465 Shares of AN2 THERAPEUTICS INC for $0.00 on 10/12</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6480528" ></link>
<id>urn:uuid:dcc2226e-62a2-3858-7df3-123da1d8500a</id>
<updated>2026-10-13T17:12:13-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: TRENOR CAMERON C III (O) Acquired (JB) 116,667 Shares of AN2 THERAPEUTICS INC for $0.00 on 9/15</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6470028" ></link>
<id>urn:uuid:b2aab5ef-c150-390b-4c63-3409d0cbccb0</id>
<updated>2026-09-16T17:35:25-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 1,108 Shares of AN2 THERAPEUTICS INC for $6.02 on 9/9</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6468293" ></link>
<id>urn:uuid:8f608fae-19f7-372e-a54a-3c08d96bd7a5</id>
<updated>2026-09-11T19:45:59-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 16,119 Shares of AN2 THERAPEUTICS INC for $6.02 on 9/3-9/8</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6466421" ></link>
<id>urn:uuid:36899698-478f-761f-a6fc-6dc626221db5</id>
<updated>2026-09-08T19:42:53-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: WILLIAMS SARAH JOANNE (AO) Sold (S) 272 Shares of AN2 THERAPEUTICS INC for $5.53 on 9/1</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6465585" ></link>
<id>urn:uuid:a9a00310-1a46-ac59-9eed-e502a8419607</id>
<updated>2026-09-04T16:25:33-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: FITZPATRICK MARGARET M (DIR) Bought (B) 2,098 Shares of AN2 THERAPEUTICS INC for $5.53 on 9/1</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6463883" ></link>
<id>urn:uuid:02c1f741-3639-3320-d78f-3fb26d14ccdd</id>
<updated>2026-09-02T18:43:59-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: TRENOR CAMERON C III (O) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6460994" ></link>
<id>urn:uuid:85060aeb-dc49-81e8-c0ec-78f062d40f7d</id>
<updated>2026-08-27T14:15:57-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 35,402 Shares of AN2 THERAPEUTICS INC for $6.01 on 8/17</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6457293" ></link>
<id>urn:uuid:da5d4df1-c009-acba-1337-1d9d8266c78f</id>
<updated>2026-08-19T17:58:27-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.53. Mkt Cap:170.9mm. 10D Vol: 267,880]]></summary>
</entry>
</feed>